A strong case for third-party testing.

Fridtjof Lund-Johansen1

  • 1Department of Immunology, Oslo University Hospital, Oslo, Norway.

Elife
|November 14, 2023
PubMed
Summary

Researchers developed a strategy to find quality commercial antibodies, uncovering widespread use of non-specific antibodies and proposing solutions for future large-scale antibody validation.